All posts by imreal

Special Medicare Enrollment Period Granted Due to COVID-19


The outbreak and rapid spread of the coronavirus pandemic has made normal Medicare enrollment significantly more difficult in some areas of the country,” Rich says

With the pandemic dictating how the country operates and moves forward, the Federal Emergency Management Agency (FEMA) declared that All 50 states, the District of Columbia, and four territories have been approved for major disaster declarations to assist with additional needs identified under the nationwide emergency declaration for COVID-19.(1) In response, the Centers for Medicare and Medicaid Services (CMS) have recently granted a special enrollment period (SEP) for Medicare beneficiaries who were unable to enroll during the normal election period due to the coronavirus crisis. “The outbreak and rapid spread of the coronavirus pandemic has made normal Medicare enrollment significantly more difficult in some areas of the country,” says Dave Rich, CEO of Ensurem LLC— a growing online multi-carrier insurance brokerage. “We need to reach out to seniors living in affected areas and make sure they understand the SEP.”

As stated by the CMS, the SEP is available from the start of the incident period—which is defined as the effective date of the President’s initial emergency declaration on March 1—and for four full calendar months after (through the end of June).(2)

According to Ensurem, here are some key points regarding this policy:


  • This SEP is available nationwide to residents of all states, tribes, territories, and the District of Columbia effective March 1, 2020.*
  • This declaration does not mean that all Medicare beneficiaries get an SEP. To be eligible, beneficiaries must meet certain criteria. All other rules apply.
  • For those who qualify, the SEP opportunity will run through June 30, 2020.

*Note: Beneficiaries will not be expected to provide proof that they were affected by the pandemic-related emergency

What does this mean for beneficiaries?

  • Beneficiaries who were eligible for a different election period but were unable to enroll* in a plan during the allotted time period have until June 30, 2020, to enroll.
  • Enrollments received are effective the first day of the following month.

*Note: This applies to anyone that could have used the MA-OEP SEP but did not

Rich, whose company specializes in the Medicare market, notes that navigating the vast array of coverage options and making the best decision can be daunting—nonetheless doing so amidst a pandemic. Ensurem’s goal is to facilitate the exchange of information between the rapidly growing U.S. senior population and the healthcare industry via innovative, user-friendly technology.

“The COVID-19 pandemic makes this a unique time in our history, becoming more concerning—and even frightening—for seniors every day,” Rich says.

This is a rapidly developing situation that could see changes at any time, so it is imperative for those who may be affected by this policy get the most up-to-date information possible. Ensurem’s contact center, which logs over 2,000 calls per day, is standing by to handle calls from seniors in question as to whether they are affected by these extended deadlines. The contact center has access to those FEMA-designated areas that have been impacted across the nation and is available to answer general questions pertaining to coverage options. The contact center is open Monday through Friday from 9:00 a.m. to 8:00 p.m. ET at (800) 729-5109 (TTY: 800-631-3750.)

“We cannot assume that seniors will focus on the various enrollment extensions available, or even understand them,” Rich says. “It’s critical that we communicate this to our seniors right now; up-to-date information is available through the Ensurem contact center.

About Ensurem

Ensurem, headquartered in Clearwater, FL, is a leading technology and product distribution company serving carriers and consumers within the massive U.S. senior market. The company provides end-to-end solutions for carriers, including product development, digital marketing, and consumer-centric front ends and back end. For more information, visit http://www.ensurem.com.

1. “COVID-19 Disaster Declarations.” COVID-19 Disaster Declarations | FEMA.gov, Federal Emergency Management Agency (FEMA), fema.gov/coronavirus/disaster-declarations.

2. MacDonald, Ilene. “CMS Clarifies Actual Dates of Special Enrollment Period Due to COVID-19.” RISE, 11 May 2020, risehealth.org/insights-articles/revenue-quality/cms-clarifies-actual-dates-of-special-enrollment-period-due-to-covid-19/.

# # #

Share article on social media or email:

MESOTHELIOMA LAWYERS – Find a Qualified Mesothelioma Lawyer


News Image

Mesothelioma Lawyers offer the best service that the world of asbestos has ever seen. The site provides advice and connects people with the best possible mesothelioma lawyer for any individual circumstances. No matter what the diagnosis, Mesothelioma Lawyers are the best people to help anyone to find the most appropriate lawyer for the specific conditions.

The site offers highly relevant information based on different aspects of lung damage caused by asbestos. Therefore, helping the process of choosing the right lawyer in the right area.

Mesothelioma claims can be complicated and confusing. Finding a qualified mesothelioma lawyer is an essential step for any family. The dedication to people affected by mesothelioma is second to none. Treating any asbestos disease is expensive, but Mesothelioma Lawyers believe the victim should not have to foot that bill.

Here are some of the aspects that the site will provide information about:

  • Pleural Mesothelioma – A rare but aggressive cancer that envelopes the lungs and chest wall. Affecting ~3,000 people per year, you need a specialist lawyer to get you the right compensation.
  • Peritoneal Mesothelioma – Another aggressive and rare cancer, but of the peritoneum. This mesothelioma accounts for 7-20% of all malignant cases.
  • Pericardial Mesothelioma – Extremely rare, affecting the lungs, abdominal cavity and heart.
  • Mesothelioma and Asbestos Trust Funds – These trust funds are to compensate people diagnosed with asbestos-related diseases. The site also contains a list of the inactive trust funds
  • Mesothelioma Symptoms – As symptoms often occur many years after exposure, it is vital to understand and recognize the signs as early as possible.
  • Asbestos Legal – This section allows the calculation of compensation, find lawyers, law firms, and other vital, legal information.
  • Veterans and Mesothelioma – There is also a dedicated section for armed forces veterans.

The truth of it is that, unfortunately, people have been exposed to asbestos for a long time. That fact raises another disturbing fact; people will get asbestos-related diseases. The only thing that anyone can do is to prepare and be there for the people who need help.

The mission is simple: Connect people diagnosed with mesothelioma with a leading lawyer to pursue the highest compensation possible. Furthermore, to give people the most relevant information that there is for anyone that is affected by all and any asbestos-related diseases.

Mesothelioma Lawyers have worked with thousands of people. Furthermore, they have helped in some of the largest settlements in the world. The largest recorded settlement is an enormous $250 Million, and negligent companies have already set aside over $30 Billion ready to pay the compensation that far too many people deserve.

For any further information, make sure that you visit mesitheliomalawyers.com today.

MEDIA CONTACT:

WEBSITE: https://mesotheliomalawyers.com/

PHONE NUMBER: 1-800-966-2244

EMAIL: info@mesotheliomalawyers.com

Share article on social media or email:

Dr. Kent Sasse Earns Patent for New Device to Make Sleeve Gastrectomy Safer


Dr. Kent Sasse

Today Dr. Kent Sasse announced the issuance of a non-provisional patent for his new sleeve tube device, a major breakthrough in the field of metabolic surgery. Millions with type 2 diabetes will benefit from Dr. Sasse’s revolutionary device – the best cure for diabetes.

The new device, Non-Provisional Patent Serial No. 15/838,057, H & H Reference No. (88537.0006), is designed to improve the sleeve gastrectomy procedure, a metabolic surgery that reduces the risk of life-threatening weight-related health conditions, including type 2 diabetes.

Unlike previous devices, the sleeve tube takes its shape from the natural contours of the body and curvature of the stomach, enabling the surgeon to perform each procedure in a manner that conforms to the human body and produces a more natural result.

“The sleeve tube is the culmination of years of work to make sleeve gastrectomy safer, simpler and more effective,” says inventor Dr. Sasse. Dr. Sasse is the medical director of a nationally accredited center for metabolic and bariatric surgery that has produced a breakthrough in reducing the leak rate to 0.0% in over 2,500 consecutive sleeve gastrectomy procedures.

“Through years of study of sleeve gastrectomy, we determined where the increased pressure zones arise, and how to lower complications of leak and stenosis with this new device,” says Dr. Sasse. With continuing innovations like the Sleeve Tube, Dr. Sasse says, “Metabolic surgery today is a 45-minute procedure with four Band-aids that is safer than an appendectomy. More importantly, it is the safest and most effective treatment of type 2 diabetes today.”

About Sleeve Gastrectomy

Also known as laparoscopic sleeve gastrectomy (LSG), sleeve gastrectomy is one of the most performed and successful minimally invasive surgical procedures available today. In addition to being the safest and most effective treatment for type 2 diabetes and obesity, sleeve gastrectomy reduces the risk of heart disease, stroke, infertility, degenerative joints and obstructive sleep apnea.

Learn more about sleeve gastrectomy.

About Dr. Sasse

Kent C. Sasse MD, MPH, FACS, FASCRS, FASMBS, is an honors graduate of the University of California, San Francisco, and holds multiple board certifications including with the American Society for Metabolic and Bariatric Surgery. Dr. Sasse has received numerous honors over the course of his distinguished career and has a deep-rooted passion for teaching, innovation and metabolic health. He is a member of the faculty of the University of Nevada School of Medicine and the author of The Type II Diabetes Cure, a 2019 book on metabolic surgery and diabetes. Learn more about Dr. Sasse at http://www.sassesurgical.com.

For Media Inquiries, please contact Dr. Sasse:

(775) 829-7999

info@sassesurgical.com

Share article on social media or email:

Idaho Health Data Exchange Partners with 4medica to Eliminate Duplicate Patient Records


www.4medica.com

“HIEs working at their fullest potential are powerful forces enhancing state efforts to improve care, especially now during the COVID-19 pandemic crisis,” said Gregg Church, President of 4medica.

Idaho Health Data Exchange (IHDE) is on the fast track to improve its ability to match patients records that come from different healthcare delivery settings. Identity management is at the heart of sharing health information and is essential to building the most comprehensive and accurate health record. Today, the IHDE announced its partnership with 4medica® to implement and operate a powerful end-to-end cloud-based enterprise master patient index (eMPI) solution and sophisticated master data clean-up service to improve the health and lives of its patients statewide.

IHDE is augmenting its current eMPI software to increase the accuracy of patient matches with the proven combination of 4medica Big Data MPI™ and 4medica 1% as-a-Service™, a real-time, transactional cloud-based service that leverages innovative technologies, people and proven processes. The hybrid approach affordably, precisely and quickly assesses, normalizes and cleanses patient identity data to guarantee a 99 percent clean database, which is considered foundational for patient safety, data integrity and interoperability.

“As we onboard new technologies and processes to support new growth strategies, we’re bringing 4medica aboard to provide the most accurate patient matching and identity information in the fastest and easiest way possible to our participants,” said Hans Kastensmith, Executive Director of IHDE. “We want our data quality to be transparent, sustainable, reliable and solid to help our provider community deliver the best quality care coordination and population health management in real time.”

“HIEs working at their fullest potential are powerful forces enhancing state efforts to improve care, especially now during the COVID-19 pandemic crisis,” said Gregg Church, President of 4medica. “No single MP technology or referential matching service can solve every patient matching problem. With 4medica, medical professionals in Idaho can be confident of having the most up-to-date exact records at the right time to treat the right patients.”

Kastensmith noted that IHDE is contributing to holistic care by establishing new health data sources, such as those from various state departments, as well as incorporating behavioral health data. The ultimate goal is to give Idaho providers a well-rounded longitudinal medical record.

“Idaho is considered a rural state and hence we provide data exchange services to many critical access hospitals and rural community clinics,” Kastensmith said. “We are excited to partner with 4medica to lower our duplication issues immediately and deliver a complete picture of a patient’s medical history for better care and pandemic response purposes ─ regardless of the provider’s location.”

“Whether the patient has a ski accident and is taken to a hospital ER or is diagnosed with the coronavirus, we want every clinician who treats that individual to have the most relevant encounter data to make the most informed treatment decision,” he added.

About Idaho Health Data Exchange

The Idaho Health Data Exchange (IHDE) is a non-profit 501(c)(3) company. IHDE was created in 2008 as a result of the efforts of the Health Quality Planning Commission. The Commission was charged with promoting improved quality of care and health outcomes through investment in health information technology. IHDE is a Health Information Exchange (HIE) that enables doctors, nurses, labs, and other medical providers to securely access their patient’s electronic health information quickly, 24/7/365, to improve the speed, quality, safety, and cost of patient care. For more information, visit: https://www.idahohde.org/

About 4medica

Guaranteeing an unprecedented 1% patient record duplication rate, 4medica® solves data integrity and financial challenges to minimize patient safety and other clinical risks and achieve true clinical interoperability and transparency for patients. Our Big Data Management and Clinical Data Exchange cloud solutions help healthcare organizations facilitate patient identity management and data exchange to ensure the right data is captured at the right time, the first time. 4medica’s Perfect Order for Perfect Payment™ ensures labs and imaging centers get paid by integrating high-volume revenue cycle management services throughout the entire order management process. 4medica has processed up to 6 billion clinical results representing more than 70 million patient identities. The company connects 40,000-plus physicians to hundreds of ACOs, HIEs, HINs, hospitals, health systems, laboratories, radiology imaging centers and payers nationwide. Learn more at http://www.4medica.com.

Share article on social media or email:

COVID-19 posing unique challenges for those with post-9/11 trauma


Psychotherapist Jenn Tomko LCSW

Psychotherapist Jennifer Tomko, LCSW notices similar struggles between COVID-19 and those with post 9/11 trauma. The trend she says is adding to higher anxiety levels with survivors of both 9/11 and the COVID pandemic.

The pandemic is bringing up many frightening feelings in people, but those experiencing some of the worst anxiety are 9/11 survivors. The issues COVID-19 brings up are similar to the trauma people experienced due to Sept. 11, South Florida psychotherapist Jennifer Tomko, LCSW says.

Tomko says while a terrorist attack and a pandemic are very different, the sense of powerlessness is the same. “There are many factors that are out of everyone’s control,” says Tomko. “Witnessing patients suffer with sickness and losing their battle with Coronavirus is negatively impacting the mental state of frontline workers, as was made evident by the reported suicide of an ER doctor in New York.” Many people enter the medical and emergency response fields because it is in their nature to help, cure, and fix. Tomko says when they are unable to do so, they can experience depression, anxiety, and PTSD, to name just a few common mental health issues.

Additionally, from inhaling all of the toxic air and fumes in Manhattan, many 9/11 survivors suffer from respiratory conditions and lung disease. This puts them at a higher risk for COVID-19 being fatal if contracted, further adding to their anxiety levels.

Tomko is certified by the World Trade Center Health program Elite E-Counseling, LLC. She and a 9/11 survivor are available for broadcast, print, and digital interviews to discuss the similarities between both traumatic events. Tomko has appeared on WPTV and WPEC in West Palm Beach and has been interviewed by Woman’s Day, Thrive Global, and Medium.

Share article on social media or email:

Elsevier’s ClinicalPath Wins 2020 MedTech Breakthrough Award


News Image

ClinicalPath offers current, evidence-based guidance at every decision point to help providers move toward the ‘single best’ treatment for each patient presentation

MedTech Breakthrough, an independent market intelligence organization that recognizes the top companies, technologies and products in the global health and medical technology market, today announced that it has selected Elsevier’s ClinicalPath (formerly Via Oncology) as the winner of its “Best Computerized Decision Support Solution” award. This is the second consecutive year that Elsevier’s ClinicalPath solution has won the MedTech Breakthrough Award. Elsevier is a global leader in information analytics, specializing in science and health.

Elsevier’s ClinicalPath presents evidence-based oncology pathways embedded into the clinical workflow, and the associated analytics, to help healthcare providers make consistent, well-informed decisions for high quality cancer care. Committees of academic and community oncologists collaborate through a consistent, open process to develop the content for ClinicalPath based on current published evidence and their shared best practices.

“It’s an exciting time to be in oncology, but fast developments also make it challenging for providers to keep up with the latest research,” said John Danaher, MD, President, Global Clinical Solutions, Elsevier. “ClinicalPath offers current, evidence-based guidance at every decision point to help providers move toward the ‘single best’ treatment for each patient presentation. We support cancer centers with a predictable approach so they can standardize treatment, run successful clinical research programs and thrive in value-based care, on their path to optimal clinical and financial outcomes.”

The mission of the MedTech Breakthrough Awards is to honor excellence and recognize the innovation, hard work and success in a range of health and medical technology categories, including Robotics, Clinical Administration, Telehealth, Patient Engagement, Electronic Health Records (EHR), mHealth, Medical Devices, Medical Data and many more. This year’s fourth annual program attracted more than 3,750 nominations from over 15 different countries throughout the world.

“Elsevier’s ClinicalPath is delivering a true ‘breakthrough’ in cancer care,” said James Johnson, managing director, MedTech Breakthrough. “For example, in precision oncology, ClinicalPath helps physicians identify the appropriate biomarkers to test and offers companion treatment guidance. Institutions receive analytics on testing rates and adoption of recommended therapies to support quality programs and reimbursements. Most importantly, cancer patients benefit from opportunities to receive life-changing therapies. We see ClinicalPath as a game-changer, and MedTech Breakthrough sincerely congratulates Elsevier on their Best CDS Solution award.”

Today a growing network of over 2,500 oncologists use ClinicalPath for evidence-based decision support in their computerized workflow. ClinicalPath covers more than 97% of common cancer presentations in medical and radiation oncology to help standardize care; prompt orders for appropriate biomarker and genetic tests; connect patients to clinical trials; enable actionable insight into care patterns; and ultimately guide patient care through personalized treatment pathways.

About MedTech Breakthrough

Part of Tech Breakthrough, a leading market intelligence and recognition platform for global technology innovation and leadership, the MedTech Breakthrough Awards program is an independent program devoted to honoring excellence in medical and health related technology companies, products, services and people. The MedTech Breakthrough Awards provide a platform for public recognition around the achievements of breakthrough health and medical companies and products in categories that include Patient Engagement, mHealth, Health & Fitness, Clinical Administration, Healthcare IoT, Medical Data, Healthcare Cybersecurity and more. For more information visit MedTechBreakthrough.com.

About Elsevier

Elsevier is a global information analytics business that helps scientists and clinicians to find new answers, reshape human knowledge, and tackle the most urgent human crises. For 140 years, we have partnered with the research world to curate and verify scientific knowledge. Today, we’re committed to bringing that rigor to a new generation of platforms. Elsevier provides digital solutions and tools in the areas of strategic research management, R&D performance, clinical decision support, and professional education; including ScienceDirect, Scopus, SciVal, ClinicalPath, ClinicalKey and Sherpath. Elsevier publishes over 2,500 digitized journals, including The Lancet and Cell, 39,000 e-book titles and many iconic reference works, including Gray’s Anatomy. Elsevier is part of RELX, a global provider of information-based analytics and decision tools for professional and business customers. elsevier.com

Share article on social media or email:

FJA Acquires Navera Assets in a Move Towards Increasing Consumer Engagement


Cartoons are an effective way to remove the anxieties around discussing insurance products.

Integrating this solution to our pioneering Unified Product Platform (UPP) completes our solution set and facilitates a carrier’s ability to connect the back-end to an engaging and compelling front-end experience.

FJA-US, Inc., a leading provider of software for the group insurance, health insurance, and property and casualty industries announced today that they have acquired the software assets of Navera (formerly Trustnode).

Navera is a decision support platform that incorporates the popular interactive agent “Harvey,” who guides users through the myriad of insurance options they have, whether at the worksite or direct-to-consumer. The application utilizes decision support tools based on animated stories and cartoon data visualizations designed to educate consumers about their insurance options. Cartoon data visualizations leverage a person’s perceptual ability, making complex insurance concepts, products and processes easier to grasp.

“Today’s technology and social trends make this solution necessary for insurance carriers. With the growth of the healthcare consumer and the push by employers to offer more voluntary and payroll deduction products, insurance companies have to find new ways to engage with their end customers. This platform does just that,” said Joe Wilds, Chief Solutions Officer at FJA.

“Integrating this solution to our pioneering Unified Product Platform (UPP) completes our solution set and facilitates a carrier’s ability to connect the back-end to an engaging and compelling front-end experience. This engagement tool is a great complement to UPP,” he continued.

Linked to an insurance knowledge base, the Navera platform enables insurance carriers, agents, and benefits brokers to quickly and easily provide a personalized online experience that more effectively engages the customer during the insurance purchasing process. Logical discussion strings engage the user in an interactive conversation and provide a relevant value proposition based on the user’s uniqueness.

“One of the major issues inhibiting the life and health industry’s ability to create better engagement is that the products they sell, while necessary, foster anxiety. Cartoons and storytelling are an effective way to remove the anxiety of discussing difficult topics associated with morbidity, mortality, lifestyle and medical history,” said Kevin Dunn, Vice President of Group for FJA and former CEO / Founder of Navera.

FJA-US Inc., as a subsidiary of msg life ag, has been future-proofing insurance for 40 years. It’s important for carriers to maintain accuracy and consistency across their enterprise. FJA’s Unified Product Platform (UPP) enables insurers to underwrite opportunities and build and distribute plans. UPP empowers carriers to create new, modify existing, and retire obsolete products and services to consistently meet market demand.

Share article on social media or email:

Logically Names Deborah Lawrence New Director of HR to Spearhead Continued Growth


News Image

Logically, the leading provider of Managed IT Services to small and midsize organizations, has named Deborah Lawrence as its Director of HR.

Ms. Lawrence is leading Logically’s continued growth as it expands its footprint across the country, with a charter to create an environment in which employees thrive and the firm can continue to retain and attract top talent as it serves the needs of its customers. She is based in Raleigh, North Carolina, and will oversee HR strategy and programming, including employee relations and engagement, talent acquisition, performance management, and leadership development and coaching.

“Logically has an exciting vision about the future of the Managed IT Services industry, and I am thrilled to join a very talented and passionate team”, says Deborah Lawrence, Logically’s Director of HR. “Our continued national expansion, along with our innovative suite of Managed IT Services, has created a fast-paced environment for our teams to grow and flourish. I am looking forward to the challenge of building strong employee engagement across multiple locations as we continue to bring our mission-critical information technology and services to the marketplace.”

“Deborah is an accomplished, strategic HR leader with deep experience in high-growth, multi-state environments, said Christopher Claudio, CEO of Logically. “We are delighted to have her outstanding acumen, experience and energy lead our HR efforts as we continue to build a powerful national brand.”

Ms. Lawrence is currently building a 100-day plan that will include a focus on recruiting top talent and working with the firm’s leaders and staff as she builds, a “wow” experience with an emphasis on communications and best practices across the organization.

Ms. Lawrence previously held several senior leadership positions, including the founder of Talent Forward HR and Human Resources Director of Flexential (both of Charlotte, NC).

About Logically

Logically is the leading Managed IT Service Provider (MSP) to small and midsize organizations. We take care of your Information Technology, so you can take care of business. Since 1999, we have made IT management easy and secure for hundreds of corporations, healthcare organizations, non-profits and public sector agencies. We set the standard for responsiveness and operational excellence for organizations seeking to augment existing IT teams or outsource IT completely. Logically, powered by OpLogic™, our unique Intelligent MSP platform, cost-effectively amplifies our customers’ competitiveness. We strategically implement and manage the right balance of mature and emerging information technologies that improve collaboration, security, cloud adoption, customer experiences, productivity and business results. Coupled with the support of our dedicated Care Teams, we deliver deep and complete technical expertise and customer service. As your trusted IT ally, we will run through brick walls for you. Visit http://www.logically.com to learn more.

Contact: Jennifer Noto

Jennifer.noto@logically.com

Share article on social media or email:

Eaton Square Expands Biotech Team in US


Kenneth Walz Joins Eaton Square

Kenneth Walz Joins Eaton Square

“At Popper and Company, we are excited to be bringing our deep industry expertise to Eaton Square and we look forward to helping grow the firm’s presence in life sciences and med-tech in the U.S. and globally,” Ken Walz, Partner and Principal

Eaton Square is pleased to announce its growth on the East Coast of the US with the addition of Popper and Company, a biotechnology and medical technology-focused strategy and M&A advisory firm.

This is an important step for Eaton Square as it continues to grow in the United States, linking US and Asia Pacific healthcare innovators with capital and investors.

Popper and Company, founded in 2003 by Caroline Popper, MD and Ken Walz, helps clients in clinical diagnostics, medical devices, life science tools, and digital health, providing guidance on a variety of commercialization challenges.

The biotechnology and life sciences sector is key to Eaton Square’s continued growth as a cross-border M&A and capital services firm. Given the current global environment, biotechnology is predicted to continue to be extremely active in M&A activity driven by initiatives from large global and regional pharmaceutical companies.

“Eaton Square is focused on assisting clients to grow across the US and internationally. We believe the combination of Popper and Company with our existing Life Sciences and Healthcare capabilities significantly enhances our ability to assist clients in the US and Asia Pacific to undertake transactions and attract capital globally.” Nick Weston, Managing Principal, Eaton Square.

“We are looking forward to initiating global and regional cross-border solutions for pharma, biotech and med-tech sectors. These now include M&A, debt and equity solutions, strategy and advisory. This will give Eaton Square a strong biotech, healthcare, device and A.I. presence in the US and Asia Pacific,” Bob Atwill, Eaton Square Principal.

“At Popper and Company, we are excited to be bringing our deep industry expertise to Eaton Square and we look forward to helping grow the firm’s presence in life sciences and med-tech in the U.S. and globally,” Ken Walz, Eaton Square Principal.

“I am excited to welcome the Popper and Company team to enable us to service more clients looking to grow in the healthcare space. Their presence in the Baltimore/DC area will also strengthen our presence in the East Coast of the United States,” Reece Adnams, Eaton Square CEO.

Joining the Eaton Square Biotech team are:

Ken Walz

Principal

Ken Walz has worked for more than 25 years in the biotech, diagnostics, and medical device industries in business development and finance roles and is particularly interested in the application of disruptive technologies to address inefficiencies in the healthcare system. He brings broad experience in commercial operations and strategy development and has extensive experience leading transaction processes. At Popper and Company, he assists clients in all aspects of strategy and corporate development including strategic partnership development, transaction process management, and health economic modeling.

Prior to Popper and Company, Ken held senior positions at MDS Proteomics and Becton Dickinson. Ken holds a BA in Economics from the University of Maryland Baltimore County and an MS in Finance from Loyola College of Maryland.

Caroline Popper, MD

Principal

Caroline is a physician with more than 25 years of hands-on operating experience within health care companies. She has managed a wide spectrum of diagnostics, device and drug discovery businesses in both Fortune 500 and start-up settings, at amongst others, Becton Dickinson, bioMerieux, and MDS. She co-founded Popper and Company with Ken Walz specifically to bring integrated strategic and operational expertise to healthcare clients. She earned her medical degree at the University of the Witwatersrand, South Africa and completed post-graduate training in internal medicine and pathologist at Johns Hopkins in Baltimore. She also trained in Health Policy and Health Economics at the Johns Hopkins Bloomberg School of Public Health.

Eaton Square, a cross-border M&A and capital services firm, now has a total of 19 offices across the US, Canada, China & Hong Kong, Australia, New Zealand, UK, Switzerland, Singapore and Israel.

If you would like to arrange a time to speak with our Life Sciences and Healthcare team, please contact them at:

Ken Walz – ken.walz@eatonsq.com

Caroline Popper – caroline.popper@eatonsq.com

Bob Atwill – bob.atwill@eatonsq.com

Nick Weston – nicholas.weston@eatonsq.com

Reece Adnams – reece.adnams@eatonsq.com

Share article on social media or email:

Omada Health Acquires Physera


As an increasing number of patients turn to remote care, Omada Health today announced the acquisition of Physera, a leading musculoskeletal care company that delivers interventions digitally and via telehealth. The offering includes video access to a nationwide network of licensed physical therapists for diagnosis and treatment, as well as in-application animations, voice prompts, digital exercise therapy, and other guidance designed to reduce musculoskeletal pain.

Through the deal, Omada adds Physera’s musculoskeletal solution to its suite of digital care programs for the prevention and self-management of diabetes, hypertension, and mental health. Omada will begin offering the musculoskeletal program immediately, making the company the most comprehensive provider of digital care in the market.

Over the last three months as the COVID-19 pandemic has necessitated shelter in place orders across the country, telehealth visits for chronic care, physical therapy, mental health, and other care needs have risen significantly. Omada’s programs address all of the most prevalent and costly health issues for employers and health plans. Omada’s acquisition of Physera broadens their portfolio, while extending a focus on depth of care and clinical rigor.

“Integrating a digital physical therapy solution better equips Omada to meet the pressing needs of the current moment, and accelerates our progression towards a fully integrated care experience to address the needs of our partners and participants,” said Omada CEO and co-founder Sean Duffy. “We’ve long believed that human-led digital care should be the first option for those dealing with chronic conditions, mental health issues, and a host of other needs. Today’s announcement positions us to deliver true whole-person care, and true value, better than any other digital health company.”

More than half of Americans report a chronic musculoskeletal condition in any given year, and nearly one in five healthcare visits are for a musculoskeletal issue. Total spending on musculoskeletal conditions in the United States exceeds $200 billion annually, with an average cost of $7,800 per person. More than 75 percent of patients with Type 2 diabetes or obesity report having at least one joint mobility issue, making Physera’s musculoskeletal capabilities a natural addition to Omada’s chronic disease program.

“Omada has been a pioneer in developing evidence-based, clinically rigorous programs that deliver real-world results,” said Dan Rubinstein, CEO of Physera. “They’ve designed programs that deliver outcomes at scale while never forgetting a fundamental truth: in healthcare, human connection matters, especially when that care is delivered digitally. It’s a philosophy we’ve shared at Physera, and we are excited to join the Omada team.”

Physera achieves clinical outcomes and reduces spend by preempting avoidable treatments and procedures including prescriptions for opioids, specialist visits, imaging, and surgery. Physera is available through employers and health plans, as well as direct-to-consumers. The company’s results demonstrate better health outcomes and lower costs than traditional approaches to musculoskeletal care.

In conjunction with the acquisition, Omada raised an additional round of growth capital from Perceptive Advisors, a leading life sciences investment firm, to finance the deal and support future company growth. “Omada’s vision for, and progression towards, creating a true digital care provider is a perfect example of where healthcare is headed,” said Sam Chawla, Portfolio Manager at Perceptive. “Adding an MSK solution to their offering accelerates that progression, and made Omada an even more attractive opportunity for us.”

About Omada Health

Omada Health is a leading digital care company that offers innovative and clinically effective digital health programs to empower individuals to engage in their health and lead healthier lives. The program is personalized to meet each participant’s unique needs as they evolve, ranging from diabetes prevention, type 2 diabetes management, hypertension, behavioral health, and musculoskeletal issues. Omada combines professional health coaching, connected health devices, real-time data and personalized feedback to deliver clinically meaningful results. The company is the largest CDC-recognized provider of the National Diabetes Prevention Program. To learn more, visit http://www.omadahealth.com.

For more information, contact:

Adam Brickman

(914) 548-3748

Press@Omadahealth.com

Share article on social media or email: